Advertisement

Rheumatology International

, Volume 37, Issue 9, pp 1489–1498 | Cite as

Vitamin D supplementation for the management of knee osteoarthritis: a systematic review of randomized controlled trials

  • Salman Hussain
  • Ambrish Singh
  • Mohd Akhtar
  • Abul Kalam Najmi
Clinical Trials

Abstract

Conflicting evidence exists concerning the supplementation of vitamin D in knee osteoarthritis condition. This systematic literature review was done to explore the effects of vitamin D supplementation in the management of knee osteoarthritis. Electronic literature search was done in databases like PubMed®, Embase®, and Cochrane CENTRAL from inception to 6th July 2016. The quality of included Randomized Controlled Trials (RCTs) was assessed using Cochrane risk of bias tool. We considered change in Western Ontario and McMaster Universities (WOMAC) index, Visual Analog Scale (VAS) and Functional Pain Score (FPS) as the primary outcome measure. Change in tibial cartilage thickness, joint space width and safety profile was considered as secondary outcomes. Participants were randomized either to treatment or placebo group. Participants received cholecalciferol as an intervention through oral route in the dose range of 800–60,000 IU except in the one study where participants received ergocalciferol. All included RCTs showed a significant increase in serum vitamin D level in the treatment group compared to the placebo group at the end point. No significant reduction in pain and function was reported on WOMAC scale except in one study. No significant difference was reported for WOMAC stiffness in any study. VAS was assessed in three studies in which two showed statistically significant improvement in knee pain. Three of the RCTs reported safety data with one incidence of calculus ureteric and hip fracture found to be related to the drug. The study found evidence from RCTs to be insufficient to support the use of vitamin D supplementation for patients with knee osteoarthritis.

Keywords

Knee osteoarthritis Systematic review Vitamin D WOMAC 

Notes

Compliance with ethical standards

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Funding

None.

Supplementary material

296_2017_3719_MOESM1_ESM.docx (24 kb)
Supplementary material 1 (DOCX 24 kb)

References

  1. 1.
    Musculoskeletal conditions—the second greatest cause of disability. Available at: http://bjdonline.org/musculoskeletal-conditions-the-second-greatest-cause-of-disability-2/. Accessed 2 Oct 16
  2. 2.
    March L, Smith EU, Hoy DG, Cross MJ, Sanchez-Riera L, Blyth F et al (2014) Burden of disability due to musculoskeletal (MSK) disorders. Best Pract Res Clin Rheumatol 28(3):353–366CrossRefPubMedGoogle Scholar
  3. 3.
    Zhang Y, Jordan JM (2010) Epidemiology of osteoarthritis. Clin Geriatr Med 26(3):355–369CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Michaud CM, McKenna MT, Begg S, Tomijima N, Majmudar M, Bulzacchelli MT et al (2006) The burden of disease and injury in the United States 1996. Popul Health Metr 4:11CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ackerman IN, Bucknill A, Page RS, Broughton NS, Roberts C, Cavka B et al (2015) The substantial personal burden experienced by younger people with hip or knee osteoarthritis. Osteoarthr Cartil 23(8):1276–1284CrossRefPubMedGoogle Scholar
  6. 6.
    Hawker GA, Stewart L, French MR, Cibere J, Jordan JM, March L et al (2008) Understanding the pain experience in hip and knee osteoarthritis—an OARSI/OMERACT initiative. Osteoarthr Cartil 16(4):415–422CrossRefPubMedGoogle Scholar
  7. 7.
    Agaliotis M, Mackey MG, Jan S, Fransen M (2014) Burden of reduced work productivity among people with chronic knee pain: a systematic review. Occup Environ Med 71(9):651–659CrossRefPubMedGoogle Scholar
  8. 8.
    Leardini G, Salaffi F, Caporali R, Canesi B, Rovati L, Montanelli R et al (2004) Direct and indirect costs of osteoarthritis of the knee. Clin Exp Rheumatol 22(6):699–706PubMedGoogle Scholar
  9. 9.
    Ruiz D, Koenig L, Dall TM, Gallo P, Narzikul A, Parvizi J et al (2013) The direct and indirect costs to society of treatment for end-stage knee osteoarthritis. J Bone Jt Surg Am 95(16):1473–1480CrossRefGoogle Scholar
  10. 10.
    Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C (2004) The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 63(4):395–401CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Murphy L, Helmick CG (2012) The impact of osteoarthritis in the United States: a population-health perspective. Am J Nurs 112(3 Suppl 1):S13–S19CrossRefPubMedGoogle Scholar
  12. 12.
    Buckwalter JA, Saltzman C, Brown T (2004) The impact of osteoarthritis: implications for research. Clin Orthop Relat Res 427:S6–S15CrossRefGoogle Scholar
  13. 13.
    McAlindon T, LaValley M, Schneider E, Nuite M, Lee JY, Price LL et al (2013) Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 309(2):155–162CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81(3):353–373CrossRefPubMedGoogle Scholar
  15. 15.
    McAlindon TE, Felson DT, Zhang Y, Hannan MT, Aliabadi P, Weissman B et al (1996) Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med 125(5):353–359CrossRefPubMedGoogle Scholar
  16. 16.
    Ding C, Cicuttini F, Parameswaran V, Burgess J, Quinn S, Jones G (2009) Serum levels of vitamin D, sunlight exposure, and knee cartilage loss in older adults: the Tasmanian older adult cohort study. Arthritis Rheum 60(5):1381–1389CrossRefPubMedGoogle Scholar
  17. 17.
    Bergink AP, Uitterlinden AG, Van Leeuwen JPTM, Buurman CJ, Hofman A, Verhaar JAN et al (2009) Vitamin D status, bone mineral density, and the development of radiographic osteoarthritis of the knee: the Rotterdam Study. J Clin Rheumatol 15(5):230–237CrossRefPubMedGoogle Scholar
  18. 18.
    Sanghi D, Mishra A, Sharma AC, Singh A, Natu SM, Agarwal S et al (2013) Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clin Orthop Relat Res 471(11):3556–3562CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Kim HJ, Lee JY, Kim TJ, Lee JW (2015) Association between serum vitamin D status and health-related quality of life (HRQOL) in an older Korean population with radiographic knee osteoarthritis: data from the Korean national health and nutrition examination survey (2010–2011). Health Qual Life Outcomes 13:48CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Wang X, Cicuttini F, Jin X, Wluka AE, Han W, Zhu Z et al (2017) Knee effusion-synovitis volume measurement and effects of vitamin D supplementation in patients with knee osteoarthritis. Osteoarthr Cartil. doi: 10.1016/j.joca.2017.02.804 Google Scholar
  21. 21.
    Koeckhoven E, van der Leeden M, Roorda LD, van Schoor NM, Lips P, de Zwart A et al (2016) The association between serum 25-hydroxy vitamin D level and upper leg strength in patients with knee osteoarthritis: results of the Amsterdam Osteoarthritis Cohort. J Rheumatol 43(7):1400–1405CrossRefPubMedGoogle Scholar
  22. 22.
    Brennan-Speranza TC, Mor D, Mason RS, Bartlett JR, Duque G, Levinger I et al (2017) Skeletal muscle vitamin D in patients with end stage osteoarthritis of the knee. J Steroid Biochem Mol Biol. doi: 10.1016/j.jsbmb.2017.01.022 Google Scholar
  23. 23.
    Warner AE, Arnspiger SA (2008) Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 14(1):12–16CrossRefPubMedGoogle Scholar
  24. 24.
    Hussain S, Singh A, Najmi AK. Vitamin D for the management of knee osteoarthritis: a systematic review of randomized controlled trials. 2015; PROSPERO:CRD42015027920Google Scholar
  25. 25.
    Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349:g7647CrossRefPubMedGoogle Scholar
  27. 27.
    Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Seida JK et al (2009) Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 339:b4012CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Review Manager (RevMan) [Computer program] (2014). Version 53 Copenhagen: The Nordic Cochrane Centre, The Cochrane CollaborationGoogle Scholar
  29. 29.
    Cao Y, Jones G, Cicuttini F, Winzenberg T, Wluka A, Sharman J et al (2012) Vitamin D supplementation in the management of knee osteoarthritis: study protocol for a randomized controlled trial. Trials 6(13):131CrossRefGoogle Scholar
  30. 30.
    Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme Version.1:b92. 2006Google Scholar
  31. 31.
    Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W et al (2016) Effect of vitamin D supplementation on tibial cartilage volume and knee pain among patients with symptomatic knee osteoarthritis: a randomized clinical trial. JAMA 315(10):1005–1013CrossRefPubMedGoogle Scholar
  32. 32.
    Arden NK, Cro S, Sheard S, Doré CJ, Bara A, Tebbs SA et al (2016) The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial. Osteoarthr Cartil 24(11):1858–1866CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Heidari B, Heidari P, Samari E, Ramzannia Jalali M (2014) Frequency of vitamin D deficiency in common musculoskeletal conditions. J Babol Univ Med Sci 16(7–15):28Google Scholar
  34. 34.
    Goula T, Kouskoukis A, Drosos G, Tselepis AS, Ververidis A, Valkanis C et al (2015) Vitamin D status in patients with knee or hip osteoarthritis in a Mediterranean country. J Orthop Traumatol 16(1):35–39CrossRefPubMedGoogle Scholar
  35. 35.
    Muraki S, Dennison E, Jameson K, Boucher BJ, Akune T, Yoshimura N et al (2011) Association of vitamin D status with knee pain and radiographic knee osteoarthritis. Osteoarthr Cartil 19(11):1301–1306CrossRefPubMedGoogle Scholar
  36. 36.
    Felson DT, Niu J, Clancy M, Aliabadi P, Sack B, Guermazi A et al (2007) Low levels of vitamin D and worsening of knee osteoarthritis: results of two longitudinal studies. Arthritis Rheum 56(1):129–136CrossRefPubMedGoogle Scholar
  37. 37.
    Konstari S, Paananen M, Heliövaara M, Knekt P, Marniemi J, Impivaara O et al (2012) Association of 25-hydroxyvitamin D with the incidence of knee and hip osteoarthritis: a 22-year follow-up study. Scand J Rheumatol 41(2):124–131CrossRefPubMedGoogle Scholar
  38. 38.
    Reginster JY, Pelousse F (2013) Supplementation with vitamin D did not reduce cartilage volume loss or pain in knee osteoarthritis. Ann Intern Med 158(8):9CrossRefGoogle Scholar
  39. 39.
    Alkan SE, Karagoz A, Genc H, Cakit BD, Taskin S, Erdem HR (2014) THU0197 The effects of vitamin D levels on pain intensity, muscle strength and functional status of the elderly patients with knee osteoarthritis. Ann Rheum Dis 73(Suppl 2):249–250Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Salman Hussain
    • 1
  • Ambrish Singh
    • 2
  • Mohd Akhtar
    • 3
  • Abul Kalam Najmi
    • 3
  1. 1.Division of Pharmacology, Department of Pharmaceutical MedicineJamia Hamdard (Hamdard University)New DelhiIndia
  2. 2.Centre of BiotechnologyAnna UniversityChennaiIndia
  3. 3.Department of Pharmacology, Faculty of PharmacyJamia Hamdard (Hamdard University)New DelhiIndia

Personalised recommendations